Advanced Enzyme Technologies Limited (BOM:540025)
India flag India · Delayed Price · Currency is INR
299.95
-3.55 (-1.17%)
At close: Aug 21, 2026

BOM:540025 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,6871,3111,3331,0561,196
Depreciation & Amortization
349.67329.75317.74318.81312.03
Other Amortization
51.4435.9934.8631.6638.41
Loss (Gain) From Sale of Assets
1.04-2.172.37.99-11.5
Asset Writedown & Restructuring Costs
3.63-0.686.87-
Loss (Gain) From Sale of Investments
-96.57-81.24-108.4821.98-3.25
Stock-Based Compensation
48.634.4630.31--
Provision & Write-off of Bad Debts
-5.4715.311.816.791.32
Other Operating Activities
-326.28-95.9753.95-43.46-35.93
Change in Accounts Receivable
-258.64-177.299.12-99.54-14.04
Change in Inventory
-162.47-77.97-238.347.55-260.95
Change in Accounts Payable
194.7234.87-39.4160.2827.98
Change in Other Net Operating Assets
80.998.096.128.3-26.98
Operating Cash Flow
1,5681,4251,4141,4041,223
Operating Cash Flow Growth
10.02%0.80%0.72%14.78%-24.96%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-522.3-338.08-423.13-381.05-281.16
Sale of Property, Plant & Equipment
4.475.271.552.5413.01
Sale (Purchase) of Intangibles
-1.47-9.73-50-0.76-0.6
Investment in Securities
-404.09-647.9-304.3-2,682218.6
Other Investing Activities
182.0999.43129.3979.212.28
Investing Cash Flow
-741.3-891.01-646.49-2,982-37.87

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
2.78-127.0326.22-
Long-Term Debt Issued
-22.3--6.74
Total Debt Issued
2.7822.3127.0326.226.74
Short-Term Debt Repaid
--58.08---64.92
Long-Term Debt Repaid
-93.98-69.72-66.97-67.99-83.55
Total Debt Repaid
-93.98-127.8-66.97-67.99-148.47
Net Debt Issued (Repaid)
-91.2-105.560.06-41.77-141.73
Issuance of Common Stock
9.533.78-0.864.34
Common Dividends Paid
-581.78-570.3-559.12-111.85-100.6
Other Financing Activities
-40.21-53.42-93.32-105.22-247.01
Financing Cash Flow
-703.66-725.44-592.38-257.98-485

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
22.5-3.78-1.51126.6254.32
Miscellaneous Cash Flow Adjustments
---0.2-
Net Cash Flow
145.3-195.26173.31-1,709754.36

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,0451,087990.561,023941.75
Free Cash Flow Growth
-3.81%9.72%-3.13%8.58%-34.38%
Free Cash Flow Margin
14.02%17.07%15.88%18.91%17.79%
Free Cash Flow Per Share
9.339.718.859.148.42
Levered Free Cash Flow
668.22737.6867.13818.74723.84
Unlevered Free Cash Flow
684.65759.84885.43833.87735.06

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
24.2133.4229.2524.2117.76
Cash Income Tax Paid
651.27596.74492.34366.39545.31
Change in Working Capital
-145.49-122.3-262.53-3.41-273.99